In summary, our findings demonstrate that HOXD9 induces cell proliferation, cell cycle progression, apoptosis suppression, migration and invasion, as well as enhances PD-L1 expression of NSCLC cells via trans-activation of ANGPT2. This evidence concerns the gene CD274 and non-small cell lung carcinoma.